Mirum Pharmaceuticals (MIRM) Share-based Compensation Growth (3y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 20.65% |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn | 61.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.71% |
| Dec 31, 2025 | 40.25% |
| Sep 30, 2025 | 37.93% |
| Jun 30, 2025 | 40.62% |
| Mar 31, 2025 | 34.05% |
| Dec 31, 2024 | 33.54% |
| Sep 30, 2024 | 17.11% |
| Jun 30, 2024 | 34.88% |
| Mar 31, 2024 | 29.40% |
| Dec 31, 2023 | 39.52% |
| Sep 30, 2023 | 34.74% |
| Jun 30, 2023 | 41.11% |
| Mar 31, 2023 | 49.29% |
| Dec 31, 2022 | 49.42% |
| Sep 30, 2022 | 47.70% |
| Jun 30, 2022 | 59.36% |
| Mar 31, 2022 | 211.06% |